EXHIBITION PREVIEW
designed to meet the diverse and growing needs of laboratories worldwide. Over the years, ELITech Molecular Diagnostics has developed a comprehensive suite of PCR technologies, including the revolutionary Minor Groove Binder (MGB). In 2016, ELITechGroup introduced ELITe InGenius, its first fully automated sample- to-result system. Since then, the company has continued to expand the platform’s capabilities, offering nearly 60 CE-IVD parameters and validating over 20 different sample matrices.
Don Whitley Scientific.
in diagnostic PCR assays. Culture Collections’ products and associated services support the scientific community with integrity, quality and expertise.
www.culturecollections.org.uk
Don Whitley Scientific Don Whitley Scientific (DWS) has expanded its portfolio with the recent launch of the OCEAView range, a web and mobile solution designed to support environments that demand specific and consistent ambient conditions. This product is an ideal solution for tracking, temperature, humidity, pressure, CO2
, light, and more. Whether you’re
safeguarding research, maintaining sensitive storage conditions, or ensuring regulatory compliance, the OCEAView range is your trusted partner. As well as being authorised to sell a range of COPAN automated laboratory solutions, DWS supplies a wide range of COPAN LBM swabs, including eSwab, eNAT and SRK. These swabs incorporate unique FLOQ tips in various sizes and are certified for rapid antigen testing, EIA, PCR and molecular-based assays, DFA and cytology testing, bacteriology and virology.
DWS is best known, however, for its range of world-renowned, modified atmosphere workstations, which create precise, customisable environments suitable for a diverse array of microbiology and cell culture applications. At this year’s BSMT meeting, we can talk you through our whole Whitley Workstation range using our interactive screen.
www.dwscientific.com
ELITech Group ELITech Molecular Diagnostics, part of the Bruker Corporation, is a leading provider of molecular diagnostics solutions,
22 Building on this success,
ELITech launched the ELITe BeGenius (pictured) in 2021, its second sample- to-result platform, further solidifying its commitment to delivering superior workflow efficiency and guaranteed performance. ELITe InGenius and ELITe BeGenius systems are easy-to-use sample-to-result solutions dedicated to molecular diagnostics which integrate extraction, amplification and result interpretation with unprecedented flexibility and assay menu possibility.
www.elitechgroup.com
ELITech Group.
Genetic Signatures. Value driven solutions are delivered
by improved laboratory workflow with reduced hands-on time and improved ease of use. The workflow supports up to 42 samples per run or 84 samples in an eight-hour shift (up to 2,016 results). User- friendly, innovative results interpretation software also allows auto-validation and release of negative results, further improving the time to result. The EasyScreen Pan-Enteric Detection Kit enables a single ‘test’ for all samples from in-patient or GP services to support infection control efforts and contribute to effective disease surveillance. Genetic Signatures’ diagnostic assays are underpinned by proprietary 3base technology which reduces the genetic complexity of detecting pathogens to improve multiplex PCR efficiency.
www.geneticsignatures.com
Launch Diagnostics Launch Diagnostics is a leading independent distributor of in vitro diagnostic (IVD) solutions, specialising in microbiology, virology, and molecular diagnostics for the UK diagnostic laboratory market. Since 1989, the firm has provided high-quality diagnostic reagents and instrumentation to support accurate and timely diagnostics. Launch’s extensive portfolio includes molecular PCR assays and third-party QC, lateral flow and ELISA tests for viral
Genetic Signatures Genetic Signatures’ EasyScreen Pan-Enteric Detection Kit and automated workflow enables single-step sample processing and PCR set up for detection of 24 viral, bacterial and parasite gastrointestinal pathogens in a single test. These clinically relevant pathogen targets align with the S7 Gastroenteritis Syndromic Guidelines.
Launch Diagnostics. APRIL 2025
WWW.PATHOLOGYINPRACTICE.COM
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56
